Kazakhstan’s Supreme Audit Chamber has presented parliament with findings of financial losses, expired drugs dispensed to patients, and price markups of up to 600 percent in the public drug procurement system — triggering an unprecedented legal threat from the Health Ministry and calls for sweeping reform.
